Analysis and Commentary STEVEN GROSSMAN 9/29/17 Analysis and Commentary STEVEN GROSSMAN 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Ever Wonder What FDA Was Like A Decade Ago and more Read More Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Where We're at Now and What's Coming Next Read More Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Next Funding Battle: Congress Must Deal with Budget Caps Read More Advocacy at a Glance STEVEN GROSSMAN 9/15/17 Advocacy at a Glance STEVEN GROSSMAN 9/15/17 Where to Stash the 18,000 Bodies: a Master Plan Read More Advocacy at a Glance STEVEN GROSSMAN 9/15/17 Advocacy at a Glance STEVEN GROSSMAN 9/15/17 House Passes FY 18 Omnibus Appropriations Bill Including Ag/FDA Funds Read More Analysis and Commentary STEVEN GROSSMAN 9/8/17 Analysis and Commentary STEVEN GROSSMAN 9/8/17 Some Shocks -- Some Pleasant; Some Less So Read More Advocacy at a Glance STEVEN GROSSMAN 9/8/17 Advocacy at a Glance STEVEN GROSSMAN 9/8/17 Senate Passes FY 18 CR Through December 8 and more Read More Advocacy at a Glance STEVEN GROSSMAN 9/1/17 Advocacy at a Glance STEVEN GROSSMAN 9/1/17 A "Breather", a Summary Review, and a Re-commitment Read More Advocacy at a Glance STEVEN GROSSMAN 9/1/17 Advocacy at a Glance STEVEN GROSSMAN 9/1/17 A Busy and Consequential Month for Congress and more Read More Advocacy at a Glance STEVEN GROSSMAN 8/20/17 Advocacy at a Glance STEVEN GROSSMAN 8/20/17 All Aboard for the FY 18 Rollercoaster Ride Read More Advocacy at a Glance STEVEN GROSSMAN 8/20/17 Advocacy at a Glance STEVEN GROSSMAN 8/20/17 House to Consider Appropriations Bill that Includes Ag/FDA Funding and more Read More Analysis and Commentary STEVEN GROSSMAN 8/11/17 Analysis and Commentary STEVEN GROSSMAN 8/11/17 It's Going to Get Tougher From Here Read More Advocacy at a Glance STEVEN GROSSMAN 8/11/17 Advocacy at a Glance STEVEN GROSSMAN 8/11/17 HHS Always “In Session” and more Read More Analysis and Commentary STEVEN GROSSMAN 8/4/17 Analysis and Commentary STEVEN GROSSMAN 8/4/17 The FDA Budget FY 18: Where Does the Money Come From? Read More Advocacy at a Glance STEVEN GROSSMAN 8/4/17 Advocacy at a Glance STEVEN GROSSMAN 8/4/17 FDARA Clears Senate; Needs President’s Signature to Become Law and more Read More Analysis and Commentary STEVEN GROSSMAN 7/28/17 Analysis and Commentary STEVEN GROSSMAN 7/28/17 Challenges and Threats to FDA Resources: An Update Read More Advocacy at a Glance STEVEN GROSSMAN 7/28/17 Advocacy at a Glance STEVEN GROSSMAN 7/28/17 House Passes First Appropriations Bill; Recesses Until September 5 and more Read More Analysis and Commentary STEVEN GROSSMAN 7/21/17 Analysis and Commentary STEVEN GROSSMAN 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Senate Appropriations Committee Votes for FY 18 FDA Funding at FY 17 Levels and more Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 9/29/17 Analysis and Commentary STEVEN GROSSMAN 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More
Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Ever Wonder What FDA Was Like A Decade Ago and more Read More
Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Where We're at Now and What's Coming Next Read More
Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Advocacy at a Glance STEVEN GROSSMAN 9/23/17 Next Funding Battle: Congress Must Deal with Budget Caps Read More
Advocacy at a Glance STEVEN GROSSMAN 9/15/17 Advocacy at a Glance STEVEN GROSSMAN 9/15/17 Where to Stash the 18,000 Bodies: a Master Plan Read More
Advocacy at a Glance STEVEN GROSSMAN 9/15/17 Advocacy at a Glance STEVEN GROSSMAN 9/15/17 House Passes FY 18 Omnibus Appropriations Bill Including Ag/FDA Funds Read More
Analysis and Commentary STEVEN GROSSMAN 9/8/17 Analysis and Commentary STEVEN GROSSMAN 9/8/17 Some Shocks -- Some Pleasant; Some Less So Read More
Advocacy at a Glance STEVEN GROSSMAN 9/8/17 Advocacy at a Glance STEVEN GROSSMAN 9/8/17 Senate Passes FY 18 CR Through December 8 and more Read More
Advocacy at a Glance STEVEN GROSSMAN 9/1/17 Advocacy at a Glance STEVEN GROSSMAN 9/1/17 A "Breather", a Summary Review, and a Re-commitment Read More
Advocacy at a Glance STEVEN GROSSMAN 9/1/17 Advocacy at a Glance STEVEN GROSSMAN 9/1/17 A Busy and Consequential Month for Congress and more Read More
Advocacy at a Glance STEVEN GROSSMAN 8/20/17 Advocacy at a Glance STEVEN GROSSMAN 8/20/17 All Aboard for the FY 18 Rollercoaster Ride Read More
Advocacy at a Glance STEVEN GROSSMAN 8/20/17 Advocacy at a Glance STEVEN GROSSMAN 8/20/17 House to Consider Appropriations Bill that Includes Ag/FDA Funding and more Read More
Analysis and Commentary STEVEN GROSSMAN 8/11/17 Analysis and Commentary STEVEN GROSSMAN 8/11/17 It's Going to Get Tougher From Here Read More
Advocacy at a Glance STEVEN GROSSMAN 8/11/17 Advocacy at a Glance STEVEN GROSSMAN 8/11/17 HHS Always “In Session” and more Read More
Analysis and Commentary STEVEN GROSSMAN 8/4/17 Analysis and Commentary STEVEN GROSSMAN 8/4/17 The FDA Budget FY 18: Where Does the Money Come From? Read More
Advocacy at a Glance STEVEN GROSSMAN 8/4/17 Advocacy at a Glance STEVEN GROSSMAN 8/4/17 FDARA Clears Senate; Needs President’s Signature to Become Law and more Read More
Analysis and Commentary STEVEN GROSSMAN 7/28/17 Analysis and Commentary STEVEN GROSSMAN 7/28/17 Challenges and Threats to FDA Resources: An Update Read More
Advocacy at a Glance STEVEN GROSSMAN 7/28/17 Advocacy at a Glance STEVEN GROSSMAN 7/28/17 House Passes First Appropriations Bill; Recesses Until September 5 and more Read More
Analysis and Commentary STEVEN GROSSMAN 7/21/17 Analysis and Commentary STEVEN GROSSMAN 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More
Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Senate Appropriations Committee Votes for FY 18 FDA Funding at FY 17 Levels and more Read More
